Statin Intolerance clinical trials

Explore recruiting statin intolerance clinical trials.

Recruiting statin intolerance studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Statin Intolerance trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Self-Assessment Method for Statin side-effects Or Nocebo 2

Denmark

Phase III and phase IV (Integrated) EU CTIS Study details

N=1-studies In Statin-intolerance; Objectifying Nocebo Effects (NISONE)

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A randomized, double-blind, placebo-controlled study to evaluate efficacy and safety of early in hospital initiation of inclisiran treatment in patients with acute coronary syndromes: Victorion – RIDES

Germany, Hungary, Poland, France, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Statin Intolerance trials by city

Statin Intolerance in Toronto Statin Intolerance in Vancouver Statin Intolerance in Montreal Statin Intolerance in Calgary Statin Intolerance in Edmonton Statin Intolerance in Ottawa Statin Intolerance in Winnipeg Statin Intolerance in Quebec City Statin Intolerance in Hamilton Statin Intolerance in Kitchener Statin Intolerance in London Statin Intolerance in Halifax Statin Intolerance in New York Statin Intolerance in Los Angeles Statin Intolerance in Chicago Statin Intolerance in Houston

Statin Intolerance clinical trials

Recruiting statin intolerance studies right now

Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention

LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering

Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance

DESIFOR-EXPAND (MHIF)

Safety and Efficacy of LOw DOse COlchicine in Patients With STatin INTolerance: the LODOCO STINT Pilot Study

Also recruiting in Europe

Self-Assessment Method for Statin side-effects Or Nocebo 2

N=1-studies In Statin-intolerance; Objectifying Nocebo Effects (NISONE)

A randomized, double-blind, placebo-controlled study to evaluate efficacy and safety of early in hospital initiation of inclisiran treatment in patients with acute coronary syndromes: Victorion – RIDES

Statin Intolerance trials by city

Other conditions